WEEKLY REPORT

• Document Type: CREST
• Collection: General CIA Records
• Document Number (FOIA) /ESDN (CREST): CIA-RDP90M00005R000400050028-8
• Release Decision: RIPPUB
• Original Classification: K
• Document Page Count: 3
• Document Creation Date: December 27, 2016
• Document Release Date: March 13, 2013
• Sequence Number: 28
• Publication Date: October 14, 1988
• Content Type: MEMO

Declassified in Part - Sanitized Copy Approved for Release 2013/03/19: CIA-RDP90M00005R000400050028-8
OCA 88-3348
14 October 1988
MEMORANDUM FOR:
FROM:
SUBJECT:
The Director
The Deputy Director
John L. Helgerson
Director of Congressional Affairs
Weekly Report
Federal Employees Health Benefits Amendments Act. We were
successful in adding language into the conference report for a
bill which extends temporary health benefits to separated
employees, certain unmarried dependent children, and certain
former spouses. There was concern about the disclosure of the
identities of covert employees from disclosure of information
regarding them as well as annuitants, their dependents and
former spouses. This concern results from the temporary
continuation of coverage for individuals who are not Agency
employees and who, but for the report language, would be
subject to regulations promulgated by the office of Personnel
Management rather than by the Agency. The report language
makes clear that the.bill does not interfere with intelligence
agencies which. administer their own health benefits programs -
and thus allows the Director to promulgate his own regulations
to protect intelligence sourceS?and methods.
Drug Legislation. Overall, the situation on drug
legislation is very fluid and changes almost hourly. The,,
following are the latest developments as of the. time this
repottFwas prepared.
The House Intelligence Committee expressed an interest in
taking on the "drug czar" aspect of the drug legislation. We
are working with them in this effort and have provided a views
letter to the Committee which supplements the DCI's earlier
letter on the subject.
The Senate drug bill actually came to the Senate floor on
13 October with votes_on-several controversial amendments. At
the same time, the Senate appeared to be moving towards an
agreement on the bill which would allow it to more tightly
control floor debate and consideration of the many remaining
Declassified in Part - Sanitized Copy Approved for Release 2013/03/19: CIA-RDP90M00005R000400050028-8
 Declassified in Part - Sanitized Copy Approved for Release 2013/03/19: CIA-RDP90M00005R000400050028-8
amendments. Under the agreement, non-controversial amendments
would be included in a "leadership package" of amendments which
are assured of adoption; other amendments would have to be
considered individually. It appears the agreement may be
adopted soon, although this is not certain.
We are supporting elements of the Justice Department in a.
further effort on the Senate side to press Intelligence
Community interests with respect to the Senate drug czar. it
appears this may result in the acceptance, into the leadership
package, of an amendment which continues to provide
intelligence information protection and bolsters, somewhat, the
autonomy of the Director vis-a-vis the czar. We are proceeding
carefully, though, in order not to jeopardize what has been
gained to date. The terms of the amendment will not likely be
final until the "leadership" amendment is actually offered. If
successful, this will give the House Intelligence Committee
more room to maneuver'on the issue in a House-Senate conference
on the bill.
On 13 October, Senator Cohen took the Senate floor to
promote two-"drug czar" amendments, The first would strip the
Senate czar of his membership on the NSC, making him instead an
NSC advisor. The second would move the czar from Level I to
Level II on the Executive Schedule, thereby depriving him of
cabinet rank. It appears the first amendment will be accepted
in the "leadership" package, thereby assuring favorable action,
but the second will not, thereby assuring a floor debate should
Cohen wish to offer it.
At present, it appears the Senate may be in session late
into the night. and perhaps over the weekend considering the
drug bill. The House is waiting for the Senate to complete
action on the bill. If both act quickly and any conference on
the bill is relatively brief, adjournment could be as early as
October 19th.
STAT
Declassified in Part - Sanitized Copy Approved for Release 2013/03/19: CIA-RDP90M00005R000400050028-8
 Declassified in Part - Sanitized Copy Approved for Release 2013/03/19: CIA-RDP90M00005R000400050028-8
u~' r Distribution:
Original - Addressees
3 - _EXDIR
1 - Inspector General
1 - DDO
1 - DDI
1 - DDS&T
1 - DDA
1 - General Counsel
1 - Deputy General Counsel
1 - Comptroller
1 - C/NIC
1 - D/ICS
1 - D/PAO
l.- D/PERS
1 - D/OCA Chrono
1. = OCA' Record`
1 Reader Library
STAT
Declassified in Part - Sanitized Copy Approved for Release 2013/03/19: CIA-RDP90M00005R000400050028-8